Skip to content

ProDigest

Active
Private limited companyfounded 200817 yrs activeTechnologiepark-Zwijnaarde 82, 9052 Gent, BelgiumKBO/BCE: BE 0806.567.272

ProDigest has been active since 2008 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €5.16M and a net result of €33k. Equity is growing by ~5.7% per year across the filed fiscal years. Its solvency ranks better than 62% of 213 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Checked score

Score 2025
81 / 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability69▼-2
Solvency91=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €410k at 30 days acceptable
Liquidity ample (current ratio 3.07 against 2.66 in 2024; short-term debt: 27.4% and cash: 8.4% of total assets), and 34.1% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers riskneutral
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
65.9%
Return on assets
0.4%
Age of the figures
9 mo
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 72
Relative position
BE, all sectors
reference
Sector 72
lower
← fewer bankruptcies more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 17 years 0 20 y
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 02-07-2026, 29 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
29 d early
2024
69 d late
2023
36 d early
2022
34 d early
2021
33 d early
2020
36 d early
2019
55 d late
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
20-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, abbreviated schema

Equity
€5.16M▲ 0.6%
2024 · €5.13M
2018: €2.09M 2020: €3.69M 2021: €5.85M 2022: €5.86M 2023: €5.02M 2024: €5.13M
2018 → 2025
Total assets
€7.83M▲ 1.0%
2024 · €7.76M
2018: €4.84M 2020: €6.48M 2021: €8.56M 2022: €8.39M 2023: €8.74M 2024: €7.76M
2018 → 2025
Net result
€33k▼ 70.5%
2024 · €111k
2018: €9k 2020: €2.19M 2021: €2.16M 2022: €11k 2023: €-843k 2024: €111k
2018 → 2025
Working capital
€4.44M▲ 14.4%
2024 · €3.88M
2018: €1.85M 2020: €3.94M 2021: €5.92M 2022: €5.29M 2023: €4.16M 2024: €3.88M
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€5.85M-€5.86M▲ 0.2%€5.02M▼ 14.4%€5.13M▲ 2.2%€5.16M▲ 0.6%
Operating result€2.79M-€56k▼ 98.0%€-857k€93k€1k▼ 98.6%
Net result€2.16M-€11k▼ 99.5%€-843k€111k€33k▼ 70.5%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
€-1.00M€0€1.00M€2.00M€3.00MOperating result 2021: €2.79M€2.79MNet result 2021: €2.16M€2.16MOperating result 2022: €56k€56kNet result 2022: €11k€11kOperating result 2023: €-857k€-857kNet result 2023: €-843k€-843kOperating result 2024: €93k€93kNet result 2024: €111k€111kOperating result 2025: €1k€1kNet result 2025: €33k€33k20212022202320242025
The operating result falls in 2025; 2025 is 99% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €7.83M
Fixed assets €1.24M▼ 18.7%
Current assets €6.59M▲ 5.8%
Equity and liabilities €7.83M
Equity €5.16M▲ 0.6%
Debt €2.67M▲ 1.6%
The debt ratio rises from 33.9% to 34.1%. Equity and debt are higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€571k
2024 · €639k
Cash flow
€602k
2024 · €656k
Solvency
65.9%
2024 · 66.1%
Current ratio
3.07
2024 · 2.66
Quick ratio
2.88
2024 · 2.47
Debt / equity
0.52
2024 · 0.51
ROE
0.6%
2024 · 2.2%
ROA
0.4%
2024 · 1.4%
Interest coverage
15.39
2024 · 8.88
Debt
€2.67M
2024 · €2.63M
Debt ≤ 1 year
€2.15M
2024 · €2.34M
Debt > 1 year
€0
2024 · €141k
Staff costs
€3.62M
2024 · €3.57M
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€7.76M€7.83M
Fixed assets21/28€1.53M€1.24M
Intangible fixed assets21€24k€60k
Tangible fixed assets22/27€1.46M€1.13M
Plant, machinery and equipment23€1.39M€1.04M
Furniture and vehicles24€63k€98k
Assets under construction and advance payments27€0-
Financial fixed assets28€51k€50k
Current assets29/58€6.23M€6.59M
Amounts receivable after more than one year29€1.59M€1.90M
Trade receivables290€75k€75k=
Other amounts receivable291€1.51M€1.82M
Stocks and contracts in progress3€443k€393k
Stocks30/36€443k€393k
Contracts in progress37€0-
Amounts receivable within one year40/41€3.39M€3.37M
Trade receivables40€2.96M€2.85M
Other amounts receivable41€423k€516k
Current investments50/53€118k€0
Cash at bank and in hand54/58€457k€655k
Deferred charges and accrued income490/1€232k€273k
Equity and liabilities
Total equity and liabilities10/49€7.76M€7.83M
Equity10/15€5.13M€5.16M
Contributions10/11€215k€215k=
Reserves13€1.09M€1.09M=
Distributable reserves133€1.09M€1.09M=
Profit (loss) carried forward14€3.82M€3.86M
Amounts payable17/49€2.63M€2.67M
Amounts payable after more than one year17€141k€0
Financial debts170/4€141k€0
Amounts payable within one year42/48€2.34M€2.15M
Current portion of amounts payable after more than one year42€570k€141k
Financial debts43€71€5k
Credit institutions430/8€71€5k
Trade debts44€651k€555k
Suppliers440/4€651k€555k
Advances received on contracts in progress46€556k€983k
Taxes, remuneration and social security45€493k€463k
Taxes450/3€20k€4k
Remuneration and social security454/9€473k€459k
Other amounts payable47/48€73k€0
Accrued charges and deferred income492/3€141k€521k
Income statement Code20242025
Non-recurring operating income76A€0€40
Remuneration, social security and pensions62€3.57M€3.62M
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€545k€569k
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€15k€12k
Other operating charges640/8€10k€9k
Gross operating margin9900€4.23M€4.21M
Operating profit (loss)9901€93k€1k
Financial income75/76B€129k€103k
Recurring financial income75€129k€103k
Financial charges65/66B€111k€71k
Recurring financial charges65€72k€37k
Non-recurring financial charges66B€39k€34k
Profit (loss) for the period before taxes9903€111k€33k
Income taxes67/77€0-
Profit (loss) for the period9904€111k€33k
Profit (loss) for the period to be appropriated9905€111k€33k
Appropriation of the result
Profit (loss) to be appropriated9906€3.82M€3.86M
Profit (loss) brought forward from the previous period14P€3.71M€3.82M
Social balance
Average headcount (FTE)908740.539.8

The notes to these accounts (21 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
02-07
NBB filing Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
08-10
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema · 69 days late
2024
31-12
Financial Back to profitnet €111k
Net result €111k after one loss-making year.
25-06
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
31-12
Financial Weakest financial yearnet €-843k ▼8028%
Net result drops to €-843k, the lowest in the series; recovery starts the following year.
27-06
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
28-06
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
31-12
Financial Equity above €5MEq €5.85M ▲58.5%
3 profitable years in a row build equity to €5.85M.
25-06
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
31-12
Financial Highest result since 2018net €2.19M ▲24294%
Net result €2.19M, the highest in the series.
24-09
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema · 55 days late
2019
06-06
NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
28-06
NBB filing Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
22-06
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
8 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Gent · 1 establishment unit since 2008
establishment approximate The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Technologiepark-Zwijnaarde 829052 Gent
Ground area
1.5 ha
Building footprint
9,047 m²
Volume, LiDAR
114,315 m³
2 parcels, Flanders · tallest building 23.8 m, ±5 floors. Linked by address, not a title deed.
1 establishment unit
Technologiepark-Zwijnaarde 4, 9052 Gent
Manufacture of food products
since 20082.174.580.345
2 parcels
Flanders 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
44082B0137/00V000 Flanders 1.3 ha 1 · 7,125 m² 23.8 m · 5 fl.
44082B0143/00K000 Flanders 2,851 m² 1 · 1,922 m² 6.3 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Public money · subsidies and aid

Flemish government

2022 to 2025 · 18 entries · 1,254,579 EUR awarded · 718,869 EUR paid
Year Entries awardedpaid
2025 7 519,160 EUR184,264 EUR
2024 5 2,300 EUR273,331 EUR
2023 4 399,116 EUR127,664 EUR
2022 2 334,003 EUR133,610 EUR
Schemes
Onderzoeksproject
4 entries · 820,764 EUR · 347,000 EUR paid · Fonds voor Innoveren en Ondernemen
Ontwikkelingsproject
4 entries · 329,769 EUR · 329,769 EUR paid · Fonds voor Innoveren en Ondernemen
Innovatieprojecten in de context van een speerpuntcluster
4 entries · 87,873 EUR · 34,000 EUR paid · Fonds voor Innoveren en Ondernemen
Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)
4 entries · 9,969 EUR · 1,896 EUR paid · Fonds voor Innoveren en Ondernemen
Vlaams opleidingsverlof (VOV)
1 entry · 5,304 EUR · 5,304 EUR paid · Departement Werk en Sociale Economie
Show 1 more
Subsidies voor internationaal ondernemen
1 entry · 900 EUR · 900 EUR paid · Vlaams Agentschap voor Internationaal Ondernemen

European research

7 projects · 1 as coordinator · 2,681,073 EUR EU contribution
Programmes
fp7
5 entries · 1,961,409 EUR
h2020
2 entries · 719,664 EUR
Projects
Use of Microorganisms for Carotenoids Delivery: Next Generation of Probiotics for Cardiovascular Disease
fp7 · coordinator · 01-12-2013 to 31-12-2015 · 648,771 EUR · CARODEL
Satiety Innovation
fp7 · participant · 01-01-2012 to 31-12-2016 · 463,727 EUR · SATIN
New siRNA Nanotherapy for Inflammatory Bowel Diseases, targeting Janus kinases
h2020 · participant · 01-01-2017 to 30-09-2021 · 463,344 EUR · NEW DEAL
Dietary Fibers supporting Gut and Immune Function - From polysaccharide compound to health claim
fp7 · participant · 01-01-2012 to 30-06-2016 · 417,739 EUR · FIBEBIOTICS
Deciphering the fungus-host-microbiota interplay to improve the management of fungal infections
h2020 · participant · 01-01-2019 to 30-06-2023 · 256,320 EUR · FunHoMic
Show 2 more projects
Beneficial effects of dietary bioactive peptides and polyphenols on cardiovascular health in humans
fp7 · participant · 01-10-2012 to 30-09-2016 · 221,512 EUR · BACCHUS
Biopolymer Based FOOd Delivery Systems
fp7 · participant · 01-02-2014 to 31-01-2018 · 209,660 EUR · BIBAFOODS

Recognitions · licences · registrations

Legal Entity Identifier

875500ZXCIZI8R5SBQ56
live in the LEI register

Similar companies · same sector, comparable size

Of 761 companies in sector 72101 we hold annual accounts for 481. 198 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded24-09-2008
Fiscal year end31-12
Activities, NACEBEL
72101Research and development on biotechnology
74909Other professional, scientific and technical activities
74999Other professional, scientific and technical activities
72109Other research and development on natural sciences
Sources
Crossroads Bank for EnterprisesNational Bank · 17 filingsAddress and cadastre registers

Data from official sources, last processed on 19-09-2026. Scores and ratios are computed by Checked and are not a credit decision.